关于FL治疗指征?
进展期FL治疗指征通常参考标准:GELF或BNLI 标准,具体如下:
- BNLI标准来源:Lancet.2003 Aug 16;362(9383):516-22
Clinically non-aggressive disease was defined as the absence of all of:
(1) pruritus or B symptoms;
(2) rapid generalised disease progression in the preceding 3 months;
(3) life-endangering organ involvement;
(4) significant bone marrow infiltration resulting in bone marrow depression that warranted immediate chemotherapy (defined as haemoglobin <100 g/L, white cell count <3·0109/L, or platelet count <100109/L, having excluded other causes of such cytopenias);
(5) localised bone lesions detected on radiography or isotope scan (because of concern over the development of pathological fractures);
(6) renal infiltration (even if renal function was well preserved);
(7) macroscopic as opposed to microscopic liver involvement.
Macroscopic disease refers to disease visible on scans. Bulk disease alone was not an exclusion criterion.
- GELF标准来源:J Clin Oncol.1997 Mar;15(3):1110-7
Patients were considered to have a low tumor burden with the following parameters:
- nodal or extranodal tumor mass with a diameter less than 7 cm;
- involvement of fewer than three nodal sites with a diameter greater than 3 cm;
- absence of systemic symptoms; no substantial splenic enlargement;
- no serous effusion;
- absence of local risk of compression (epidural, ureteral, etc);
- no leukemia or blood cytopenia.
进展期FL治疗是以症状驱动的,起初的标准也是如此;不知道何时多了两个生化指标:LDH和微球蛋白;
比如RELEVANCE 研究的标准就是:
Patients were required to be in need of treatment according to Groupe d'Etude des Lymphomes Folliculaires (GELF) criteria as evidenced by at least one of the following: bulky disease defined as:
- a nodal or extranodal (except spleen) mass > 7 cm in its greater diameter
- involvement of at least 3 nodal or extranodal sites (each with a diameter greater than > 3 cm);
- presence of at least one of the following B symptoms: fever (> 38 degrees Celsius) of unclear etiology, night sweats, weight loss greater than 10% within the prior 6 months;
- symptomatic splenomegaly;
- compression syndrome (ureteral, orbital, gastrointestinal); any one of the following cytopenias due to lymphoma: hemoglobin < 10 g/dL (6.25 mmol/L), platelets < 100 x 109/L , or absolute neutrophil count < 1.5 x 109/L;
- pleural or peritoneal serous effusion(irrespective of cell content);
- and/or lactate dehydrogenase or β2 microglobulin greater than the upper limit or normal.
对此,有点困惑;不知大家怎么看
最后编辑于 2024-03-13 · 浏览 802